(NASDAQ:PMN), Phase 1b trial in Alzheimer's disease is over 85% enrolled: Cohorts 1 and 2 are fully enrolled PMN310 continues to demonstrate a favorable safety profile On track to report 6-month interim data in Q2 2026 and final 12-month top-line results in Q4 2026 Cambridge, Massachusetts, Nov. 12, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. […]
EARTHDAY.ORG(EDO), the global organizer of the Earth Day movement-observed by more than one billion people each April 22-celebrates the European Union's landmark decision to integrate climate education into school curricula from kindergarten through grade 12, as part of its 2025 Nationally Determined Contribution (NDC) to the Paris Agreement. https://mma.prnewswire.com/media/1155792/Earthdayorg_Logo.jpg “The inclusion of climate education in
(NasdaqGM:ATAI), BPL-003 (mebufotenin benzoate nasal spray) granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for treatment-resistant depression (TRD) Reported positive topline data from the Phase 2b open-label extension (OLE) study of BPL-003 showing the potential added and sustained antidepressant effects following a second dose in patients with TRD Reported positive open-label
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Prospect Credit REIT, LLC (“PCRED”), a non-traded real estate fund focused on real estate credit managed by an affiliate of Prospect Capital Management L.P. (“Prospect”), has closed on a credit investment to recapitalize Skyline Apartments, a 588-unit, Class A stabilized cash-flowing multifamily property in New Rochelle, NY.
(TSX-V:HPQ),(OTC US:HPQFF),(Other OTC:HPQFF),(Boerse Frankfurt – Freiverkehr:O08.F),(TSX:PYR.TO),(Other OTC:PYRGF),(Boerse Frankfurt – Freiverkehr:8PY1.F), MONTREAL, Nov. 12, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to announce that independent laboratory analysis [1]
(TSX-V:FNC), VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation“) (TSX Venture Exchange: FNC) is pleased to announce that it has signed an option agreement with Harfang Exploration Inc. (“Harfang“), whereby Fancamp, subject to the approval of the TSX Venture Exchange (“TSX-V“), has the option to acquire up
(NasdaqGM:ARTV), Over 100 patients treated with AlloNK across autoimmune and oncology indications Refractory rheumatoid arthritis (RA) prioritized as lead indication following FDA Fast Track Designation for AlloNK(R), the first known therapy within the emerging deep B-cell depletion category to receive this designation in RA Company to host webcast later this morning to discuss initial safety
(NASDAQ:OVID), Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of Directors Next-generation GABA-aminotransferase (GABA-AT) inhibitor, OV329, demonstrated strong inhibitory activity and a potential best-in-category safety profile in a Phase 1 study, supporting advancement into planned Phase 2 patient studies OV329 Phase
(NASDAQ:BYSI), Two SITC 2025 presentations: First-in-class dendritic cell (DC) maturation agent Plinabulin drives immune re-sensitization in metastatic NSCLC patients who had progressed after PD-1/L1 inhibitors with disease control rate of 85% in combination with docetaxel and Keytruda. Mechanism studies with MD Anderson collaborators showed DC maturation and M1 macrophage polarization via a Plinabulin specific GEF-H1
CHICAGO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Amplify ETFs, a leading provider of breakthrough ETF solutions, announces the filing for the Amplify HACK Cybersecurity Covered Call ETF (HAKY). The Amplify HACK Cybersecurity Covered Call ETF seeks to balance high income and capital appreciation through investment exposure to cybersecurity companies and a covered call strategy. The